LIP
WST icon

Liontrust Investment Partners’s West Pharmaceutical WST Stock Holding History

Liontrust Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144M Buy
402,233
+65,238
+19% +$19.9M 2.12% 9
2026
Q1 		$84.5M Sell
336,995
-29,193
-8% -$7.26M 1.44% 29
2025
Q4 		$101M Buy
+366,188
New +$100M 1.5% 25
2025
Q3 		– Sell
-421,601
Closed -$92.2M – 209
2025
Q2 		$92.2M Sell
421,601
-25,137
-6% -$5.37M 1.32% 34
2025
Q1 		$100M Buy
446,738
+157,954
+55% +$43.5M 1.56% 27
2024
Q4 		$94.6M Buy
288,784
+93,890
+48% +$29.5M 1.37% 30
2024
Q3 		$64.2M Hold
194,894
– – 0.91% 40
2024
Q2 		$64.2M Buy
+194,894
New +$68.9M 0.91% 40

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Liontrust Investment Partners's WST Position: Q2 2026 in Review

Liontrust Investment Partners increased its West Pharmaceutical (WST) stake by 19% in Q2 2026, buying an estimated $19.9M and bringing the position to 402,233 shares worth $144M. The position accounts for 2.12% of the portfolio, ranked #9.

Liontrust Investment Partners first reported a position in WST in Q2 2024 and has held it in 8 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Liontrust Investment Partners held 402,233 shares of West Pharmaceutical worth $144M as of Q2 2026.
  • Liontrust Investment Partners bought 65,238 West Pharmaceutical shares in Q2 2026, an estimated $19.9M.
  • West Pharmaceutical made up 2.12% of Liontrust Investment Partners's portfolio in Q2 2026, its #9 holding.
  • Liontrust Investment Partners first reported a position in West Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.